<DOC>
	<DOC>NCT00853450</DOC>
	<brief_summary>The primary purpose of this study is to evaluate the effect of AZD6482 and clopidogrel on bleeding time when taken together with low-dose ASA.</brief_summary>
	<brief_title>Bleeding Time Study With AZD6482, Clopidogrel and ASA</brief_title>
	<detailed_description />
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>BMI between 19.0 and 30.0 kg/m2, inclusive and body weight between 50.0 and 100.0 kg, inclusive Provision of written informed consent Personal or family history of bleeding disorders, or reasonable suspicion of vascular malformations, including aneurysms. Acute illness, surgical procedure or trauma from 2 weeks before preentry visit until the first baseline visit or clinically significant abnormalities in clinical chemistry, haematology, urinalysis or supine BP or pulse Known impaired glucose tolerance, known galactose intolerance, total lactase deficiency or glucosegalactose malabsorption or known or suspected Gilbert's syndrome</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Antiplatelet</keyword>
</DOC>